Stem Cell Mitochondria Delivered in Tiny Hydrogel Capsules Repair Heart Attack Damage

Heart attacks damage the cellular powerhouses called mitochondria, leading to energy depletion and cell death in heart muscle. While transplanting healthy mitochondria shows promise, current methods face major hurdles: mitochondria break down quickly outside cells, have poor uptake rates, and come from limited cell sources.

Researchers at South China University of Technology developed a novel solution using microscopic hydrogel capsules (Mito@Microgels) to deliver mitochondria from adipose stem cells. These 1-micrometer capsules protect mitochondria from damage while enhancing cellular uptake through phosphatidylserine surface modification—a natural "eat-me" signal that cells recognize.

The team tested their system in rat heart attack models. Mito@Microgels successfully delivered intact, functional mitochondria to damaged heart cells, restoring cellular energy production and reducing oxidative stress. The treatment also reduced inflammatory responses in immune cells called macrophages.

Most importantly, rats receiving Mito@Microgels showed significantly improved heart function, prevented thinning of the heart wall, and increased survival of heart muscle cells compared to controls. The gelatin-based capsules degrade naturally in response to enzymes elevated after heart attack, releasing their mitochondrial cargo precisely where needed.

This approach overcomes previous limitations by using readily available stem cells as mitochondria sources and protecting the organelles during transport. The technology could potentially treat other diseases involving mitochondrial dysfunction, including neurodegenerative disorders and metabolic diseases. However, human trials are needed to confirm safety and efficacy.